Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Endometrial Neoplasms 7 Uterine Cervical Neoplasms 6 Leiomyoma 6 Ovarian Neoplasms 4 Myofibroma 3 Uterine Neoplasms 2 FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 2 Carcinoma, Ovarian Epithelial 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Prolapse 1 Uterine Cervical Dysplasia 1 Sarcoma 1 Precancerous Conditions 1 Metrorrhagia 1 Menstruation Disturbances 1 Menorrhagia 1 Hysterectomy 1 Hereditary Breast and Ovarian Cancer Syndrome 1 Fallopian Tube Neoplasms 1 Endometriosis 1 Endometrial Hyperplasia 1 Disease 1 Carcinoma, Squamous Cell 1 Carcinoma, Endometrioid 1 Carcinoma, Adenosquamous 1 Adenomyosis 1 Adenocarcinoma 1

Interventions

Blood Specimen Collection 9 Surveys and Questionnaires 6 Magnetic Resonance Spectroscopy 6 Dexamethasone 6 Cyclophosphamide 6 Prednisone 5 Mammography 5 Colonoscopy 5 Biopsy 5 Positron Emission Tomography Computed Tomography 4 Magnetic Resonance Imaging 4 Lenalidomide 4 Biopsy, Fine-Needle 4 pembrolizumab 3 Tomography, X-Ray Computed 3 Surgical Procedures, Operative 3 Melphalan 3 Liquid Biopsy 3 Interviews as Topic 3 Exercise 3 Diagnostic Tests, Routine 3 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 3 weifuchun 2 obinutuzumab 2 fluciclovine F-18 2 daratumumab 2 carfilzomib 2 Urination 2 Preoperative Exercise 2 Positron-Emission Tomography 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Disease × Hysterectomy × Clear all

NCT06576362 2024-08-30

EFIBIA

Assistance Publique Hopitaux De Marseille

Phase NA Not yet recruiting

Disease, Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡